Skip to content

All rebalances

Short-term Top 10 — Health Care — 18 Aug 2026

The ten as they stood on 18 Aug 2026. Scores, pillars and reasons are the ones recorded that day; nothing here is recomputed. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100.

The short-term score is a published weighted sum of percentile ranks, rebalanced every Monday. A list is a published formula and its output, not a recommendation. Method version 1.

Get this list's changes by email

Who entered, who left, and the reason — with the score moves behind it.

Sign in to subscribe Subscriptions are available to signed-in accounts while email delivery is being set up.

Informational only — not financial advice. The daily email has not started yet — subscribing now puts you on the list for the first one. Unsubscribe in one click.

The ten

#CompanySectorScore
1 MINIMED INC (MMED)

Trend 95th: the price is 17% above the average price paid over the period covered, so the typical buyer over that stretch is showing a gain; volume and participation 71st: trading volume is about normal versus its 30-day average; weakest is setup 56th: no Elliott-wave labelling currently fits its swings.

  • Trend94.6
  • Momentum67.5
  • Setup56.4
  • Volume and participation70.8
  • Catalysts62.3
Health Care 71.5
2 BridgeBio Pharma, Inc. (BBIO)

Catalysts 92nd: open-market insider buys in 90 days 38, the analyst consensus rating has softened toward "sell" since the prior reading; trend 76th: a "golden cross" — its 50-day average is above its 200-day; weakest is setup 51st: a fresh 20-day low.

  • Trend76.2
  • Momentum55.5
  • Setup51.0
  • Volume and participation62.8
  • Catalysts92.0
Health Care 68.2
3 DEFINIUM THERAPEUTICS INC (DFTX)

Trend 88th: a "golden cross" — its 50-day average is above its 200-day; volume and participation 80th: it gapped 16.1% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; weakest is setup 53rd: over the past year its closes ranged, and it has retraced only a small part of its move over the past year — 6% of it.

  • Trend88.2
  • Momentum54.1
  • Setup52.5
  • Volume and participation80.0
  • Catalysts64.2
Health Care 68.2
4 Encompass Health (EHC)

Volume and participation 88th: it gapped 12.5% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; catalysts 76th: analysts have raised their average price target by 4.6% since the prior reading; weakest is setup 55th: day-to-day price swings are unusually wide versus its own recent history (wider than about 88% of the past ~6 months).

  • Trend65.1
  • Momentum59.4
  • Setup55.2
  • Volume and participation88.4
  • Catalysts76.3
Health Care 67.7
5 Veeva Systems (VEEV)

Trend 80th: the price is 28% above the average price paid over the period covered, so the typical buyer over that stretch is showing a gain; catalysts 72nd: the analyst consensus rating has softened toward "sell" since the prior reading; weakest is volume and participation 53rd: it gapped 2.0% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed.

  • Trend79.8
  • Momentum67.1
  • Setup59.7
  • Volume and participation52.5
  • Catalysts72.2
Health Care 67.6
6 IMMUNOME INC (IMNM)

Trend 92nd: the price is 26% above the average price paid over the period covered, so the typical buyer over that stretch is showing a gain; volume and participation 74th: trading volume is about normal versus its 30-day average; weakest is setup 44th: over the past year its closes ranged, and it has retraced only a small part of its move over the past year — 3% of it.

  • Trend92.4
  • Momentum61.4
  • Setup43.9
  • Volume and participation73.8
  • Catalysts60.4
Health Care 67.3
7 EDGEWISE THERAPEUTICS INC (EWTX)

Volume and participation 78th: it gapped 6.8% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; catalysts 71st: analysts have raised their average price target by 1.8% since the prior reading; weakest is setup 61st: over the past year its closes ranged, and it has retraced only a small part of its move over the past year — 12% of it.

  • Trend65.5
  • Momentum63.0
  • Setup61.2
  • Volume and participation78.4
  • Catalysts71.0
Health Care 67.2
8 Agilent Technologies (A)

Volume and participation 77th: it gapped 4.4% above the previous close and has not traded back through the level it left behind — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed; trend 71st: the price is 10% above the average price paid over the period covered, so the typical buyer over that stretch is showing a gain; weakest is catalysts 50th: open-market insider buys in 90 days 1, analysts' average price target is unchanged from the prior reading.

  • Trend70.8
  • Momentum65.5
  • Setup66.5
  • Volume and participation77.2
  • Catalysts50.0
Health Care 65.7
9 CELLDEX THERAPEUTICS INC (CLDX)

Trend 85th: it is trading 14.8% above its 50-day average, the short-term trend line; catalysts 71st: analysts have raised their average price target by 1.8% since the prior reading; weakest is volume and participation 44th: trading volume is about normal versus its 30-day average.

  • Trend85.2
  • Momentum67.7
  • Setup50.2
  • Volume and participation43.6
  • Catalysts70.9
Health Care 65.6
10 HINGE HEALTH INC CLASS A (HNGE)

Catalysts 81st: analysts have raised their average price target by 13.5% since the prior reading; trend 76th: a strong uptrend, with buyers in control; weakest is setup 41st: no Elliott-wave labelling currently fits its swings.

  • Trend76.1
  • Momentum64.4
  • Setup40.7
  • Volume and participation59.6
  • Catalysts81.4
Health Care 65.3

Entered on 18 Aug 2026

MINIMED INC (MMED) — Entered 18 Aug 2026: first selection for this list at rank 1, score 71.5.

BridgeBio Pharma, Inc. (BBIO) — Entered 18 Aug 2026: first selection for this list at rank 2, score 68.2.

DEFINIUM THERAPEUTICS INC (DFTX) — Entered 18 Aug 2026: first selection for this list at rank 3, score 68.2.

Encompass Health (EHC) — Entered 18 Aug 2026: first selection for this list at rank 4, score 67.7.

Veeva Systems (VEEV) — Entered 18 Aug 2026: first selection for this list at rank 5, score 67.6.

IMMUNOME INC (IMNM) — Entered 18 Aug 2026: first selection for this list at rank 6, score 67.3.

EDGEWISE THERAPEUTICS INC (EWTX) — Entered 18 Aug 2026: first selection for this list at rank 7, score 67.2.

Agilent Technologies (A) — Entered 18 Aug 2026: first selection for this list at rank 8, score 65.7.

CELLDEX THERAPEUTICS INC (CLDX) — Entered 18 Aug 2026: first selection for this list at rank 9, score 65.6.

HINGE HEALTH INC CLASS A (HNGE) — Entered 18 Aug 2026: first selection for this list at rank 10, score 65.3.

See every rebalance of this list →

Informational only — NOT financial advice.

Research stocks in your own words.

Informational only — NOT financial advice.

ScreenersBlogPrivacyiOS app